Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / QurAlis Corp

QurAlis Corp

Stage unknownCambridge, MAquralis.comPharmaceuticals

At QurAlis, we consider ourselves “neuro pioneers” because we are driven to explore the deepest aspects of human neurology in order to find the treatments

Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2
Financing history
1 rounds
  1. Aug 21, 2025
    Form D equity offering · $20.0M (form d sold) · 19 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “QurAlis Corp filed Form D: $19,952,387 sold of $24,921,734, Pharmaceuticals”
Investors on record
2 edges
People
4 officers, 7 directors
Timeline
1
  1. Sep 5, 2025
    QurAlis Corp filed Form D: $19,952,387 sold of $24,921,734, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
20 observations
Every observation on this company